Health News-RSS Feeds

Subscribe to Health News-RSS Feeds feed Health News-RSS Feeds is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 4 min 47 sec ago

China vaccine scandal ripples through domestic market, threatens global push

43 min 40 sec ago
A vaccine scandal in China, which has hit a nerve in the country and prompted quick reactions from leaders in Beijing, is sending ripples across the wider domestic drug market while threatening to dent Chinese ambitions to play a larger global role.

Chinese premier calls for severe punishment in vaccine scandal

3 hours 15 min ago
Chinese Premier Li Keqiang has called for an immediate investigation into a scandal over faulty vaccines that he said had crossed a moral line, and urged severe punishment for the companies and people implicated.

Cigarette use declines among U.S. young women, but marijuana blunt use rises

July 21, 2018 - 3:28am
(Reuters Health) - Cigarette use decreased among young women - including pregnant women - during the past decade in the U.S., according to a new study. But, researchers found, use of marijuana blunts rose.

CPR training should change, and maybe there should be an app for that

July 21, 2018 - 3:24am
(Reuters Health) - To help more patients survive cardiac arrest, traditional CPR training needs an overhaul with more chances for practice - and instructions on social and digital platforms might help lessons stick, some doctors argue.

'Invisible' stool blood tied to increased risk of premature death

July 21, 2018 - 2:22am
(Reuters Health) - A screening test for colon cancer that looks for "invisible" blood in stool may also predict a heightened risk of premature death from other causes, a recent study suggests.

U.S. court rejects Allergan bid to shield patents through tribe deal

July 20, 2018 - 10:48pm
A U.S. appeals court on Friday rejected a novel strategy adopted by drug company Allergan PLC to shield patents from review by an administrative court by transferring them to a Native American tribe.

Agios Pharmaceuticals leukemia drug gets U.S. approval

July 20, 2018 - 9:59pm
Agios Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration approved its treatment for a type of leukemia, the first targeted drug for patients with a specific genetic mutation.

Bayer to phase out Essure birth control device in U.S

July 20, 2018 - 9:53pm
Healthcare company Bayer on Friday said it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the implantable device which made the business no longer sustainable.

FDA approves Agios Pharmaceuticals leukemia drug

July 20, 2018 - 8:30pm
Agios Pharmaceuticals Inc said on Friday its oral drug to treat a type of leukemia was approved by the U.S. health regulator.

Virtual reality may help cure fear of heights

July 20, 2018 - 7:39pm
(Reuters Health) - A virtual reality program may work at least as well as one-on-one therapy to help people overcome a fear of heights, a UK study suggests.

Honduras appeals WTO landmark ruling on Australia's plain tobacco packaging

July 20, 2018 - 6:50pm
Honduras has appealed against a WTO ruling won last month by Australia on its "plain" packaging requirements for tobacco, a WTO spokesman said on Friday.

Swiss, German drugmakers join U.S. price freeze

July 20, 2018 - 6:31pm
Roche, Bayer and Germany's Merck KGaA became the latest drug companies to freeze prices in the United States, amid increased scrutiny by the Trump administration of medicine costs.

EU drug regulators step up work to prepare for 'no deal' Brexit

July 20, 2018 - 5:04pm
Drug regulators across Europe are hiring extra staff and increasing their workload as the role of British experts in the EU-wide system of medicines supervision winds down ahead of Brexit.

Roche gets breakthrough status for Alzheimer's test Elecsys

July 20, 2018 - 11:03am
The U.S. Food and Drug Administration has granted Roche an accelerated review for its Elecsys product used to diagnose Alzheimer's disease, the Swiss drugmaker said on Friday.

Brazil's 'Dr. Butt' plastic surgeon arrested after patient death: police

July 20, 2018 - 5:52am
A plastic surgeon known as "Dr. Bumbum" or "Dr. Butt" on social media because of his buttock-enhancement operations was arrested on Thursday in Rio de Janeiro, four days after one of his patients died, police said.

Police killings tied to worse mental health for African-Americans

July 20, 2018 - 3:47am
(Reuters Health) - Police killings of unarmed black people are associated with worse mental health for African-Americans across the country, even when they have no direct connection to the deaths, a U.S. study suggests.

Mixing alcohol and drugs poses bigger unsafe sex risk for women

July 20, 2018 - 3:40am
(Reuters Health) - Drinking alcohol and smoking pot at the same time is more likely to increase the odds of unsafe sex for young women than for men, a small U.S. study suggests.

Merck lowers prices of some drugs after Trump calls out industry

July 20, 2018 - 2:57am
Merck & Co on Thursday announced price cuts to some of its medicines, including a 60 percent reduction to a little-used hepatitis C treatment, after U.S. President Donald Trump criticized drugmakers for failing to help reduce healthcare costs for consumers.

A tenth of U.S. veteran coal miners have black lung disease: NIOSH

July 20, 2018 - 1:37am
More than 10 percent of America’s coal miners with 25 or more years of experience have black lung disease, the highest rate recorded in roughly two decades, according to a government study released on Thursday that showed cases concentrated heavily in central Appalachia.

Systemic changes may reduce gender disparities in medical training

July 20, 2018 - 12:00am
(Reuters Health) - Gender disparities in medical careers - in position, pay and publishing - start early, but even small systemic changes in training programs could begin to narrow these gaps, says a group of Harvard Medical School doctors.